
Journal of International Oncology ›› 2025, Vol. 52 ›› Issue (11): 673-679.doi: 10.3760/cma.j.cn371439-20241203-00116
• Original article • Previous Articles Next Articles
Zhang Shuai, Liu Liangliang, Huang Di, Sheng Ru, Qi Mengyao, Li Shuguang(
)
Received:2024-12-03
Revised:2025-05-06
Online:2025-11-08
Published:2025-12-21
Contact:
Li Shuguang
E-mail:lishuguang196508@163.com
Supported by:Zhang Shuai, Liu Liangliang, Huang Di, Sheng Ru, Qi Mengyao, Li Shuguang. Effects of circRNA-15430 targeting miR-10 on proliferation and invasion of gastric cancer cells[J]. Journal of International Oncology, 2025, 52(11): 673-679.
| [1] | 刘文会, 殷平, 戚洁. 血清G-17、sB7-H3、DKK1检测对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(8): 498-503. DOI: 10.3760/cma.j.cn371439-20240304-00083. |
| [2] | Yang JY, Park JH, Choi SJ, et al. Role of recurrence pattern multiplicity in predicting post-recurrence survival in patients who underwent curative gastrectomy for gastric cancer[J]. J Gastric Cancer, 2024, 24(2): 231-242. DOI: 10.5230/jgc.2024.24.e18. |
| [3] | Huang CG, Zhou XQ, Zheng AF, et al. eIF6 promotes gastric cancer proliferation and invasion by regulating cell cycle[J]. Dig Dis Sci, 2024, 69(9): 3249-3260. DOI: 10.1007/s10620-024-08464-z. |
| [4] |
Deng C, Huo M, Chu H, et al. Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to promote gastric cancer progression[J]. Mol Cancer, 2024, 23(1): 49. DOI: 10.1186/s12943-024-01966-4.
pmid: 38459596 |
| [5] | Zhou YC, Lao WJ, Xu YL, et al. Upregulation of circRNA_0023685 promotes gastric cancer progression via a circRNA-miRNA-mRNA interaction network[J]. Am J Cancer Res, 2024, 14(1): 130-144. DOI: 10.62347/TGBA1922. |
| [6] |
Zhang Y, Wang X, Liu W, et al. CircGLIS3 promotes gastric cancer progression by regulating the miR-1343-3p/PGK1 pathway and inhibiting vimentin phosphorylation[J]. J Transl Med, 2024, 22(1): 251. DOI: 10.1186/s12967-023-04625-2.
pmid: 38459513 |
| [7] | Zeng F, Zhao J, Tong M, et al. CircRNA LDLR promotes proliferation and aerobic glycolysis of gastric cancer cells by targeting CHD1 with miR-449b-5p[J]. Turk J Biol, 2024, 48(1): 46-58. DOI: 10.55730/1300-0152.2681. |
| [8] | Wang FH, Zhang XT, Tang L, et al. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2023[J]. Cancer Commun (Lond), 2024, 44(1): 127-172. DOI: 10.1002/cac2.12516. |
| [9] | Stroobant EE, Strong VE. Advances in gastric cancer surgical management[J]. Hematol Oncol Clin North Am, 2024, 38(3): 547-557. DOI: 10.1016/j.hoc.2024.01.003. |
| [10] |
Ma Q, Yang F, Xiao B, et al. Emerging roles of circular RNAs in tumorigenesis, progression, and treatment of gastric cancer[J]. J Transl Med, 2024, 22(1): 207. DOI: 10.1186/s12967-024-05001-4.
pmid: 38414006 |
| [11] | Qu B, Liu J, Peng Z, et al. Macrophages enhance cisplatin resistance in gastric cancer through the transfer of circTEX2[J]. J Cell Mol Med, 2024, 28(5): e18070. DOI: 10.1111/jcmm.18070. |
| [12] |
Li R, Wang J, Xie Z, et al. CircUSP1 as a novel marker promotes gastric cancer progression via stabilizing HuR to upregulate USP1 and vimentin[J]. Oncogene, 2024, 43(14): 1033-1049. DOI: 10.1038/s41388-024-02968-8.
pmid: 38366146 |
| [13] | Wang Y, Chen X, Yang Y. CircRNA-regulated glucose metabolism in ovarian cancer: an emerging landscape for therapeutic intervention[J]. Clin Transl Oncol, 2024, 26(3): 584-596. DOI: 10.1007/s12094-023-03285-4. |
| [14] | Dai T, Qiu S, Gao X, et al. Circular RNA circWNK1 inhibits the progression of gastric cancer via regulating the miR-21-3p/SMAD7 axis[J]. Cancer Sci, 2024, 115(3): 974-988. DOI: 10.1111/cas.16067. |
| [15] | Liu F, Shi Y, Liu Z, et al. The emerging role of miR-10 family in gastric cancer[J]. Cell Cycle, 2021, 20(15): 1468-1476. DOI: 10.1080/15384101.2021.1949840. |
| [16] |
Huang X, Liu Y, Qian C, et al. CHSY3 promotes proliferation and migration in gastric cancer and is associated with immune infiltration[J]. J Transl Med, 2023, 21(1): 474. DOI: 10.1186/s12967-023-04333-x.
pmid: 37461041 |
| [17] |
Ma S, Xu Y, Qin X, et al. RUNX1, FUS, and ELAVL1-induced circPTPN22 promote gastric cancer cell proliferation, migration, and invasion through miR-6788-5p/PAK1 axis-mediated autophagy[J]. Cell Mol Biol Lett, 2024, 29(1): 95. DOI: 10.1186/s11658-024-00610-9.
pmid: 38956466 |
| [18] | 崔逸爽, 郑璇, 吴亚男, 等. RNA结合蛋白QKI可通过调节EMT相关基因转录物的切割形成circRNA促进胃癌的发生发展[J]. 中国药理学通报, 2024, 40(8): 1462-1473. DOI: 10.12360/CPB202401068. |
| [19] | 白文筠, 梁峻尉, 王晓燕. 胃癌前病变和胃癌差异表达的mRNA、circRNA调控网络及关键调控轴的鉴定[J]. 中国老年学杂志, 2024, 44(10): 2327-2336. |
| [20] |
Liu Y, Cao J, Yang Q, et al. CircRNA_15430 reduced by Helicobacter pylori infection and suppressed gastric cancer progression via miR-382-5p/ZCCHC14 axis[J]. Biol Direct, 2023, 18(1): 51. DOI: 10.1186/s13062-023-00402-9.
pmid: 37626393 |
| [1] | Wang Mengju, Wang Xia. Anti-tumor effect and immunomodulatory mechanism of atractylenolide Ⅱ on colon cancer mice [J]. Journal of International Oncology, 2025, 52(9): 545-553. |
| [2] | Liu Mei, Hu Yuchong, Li Fengtong, Chao Lemen, Liu Meng, Kang Linlin. Mechanism of action of SHCBP1 in malignant tumors and progress in clinical research [J]. Journal of International Oncology, 2025, 52(9): 583-586. |
| [3] | Li Guangxin, Quan Huijuan, Gao Zhijuan, Wang Xiaojun, Li Liang, Dong Qian, Miao Yongtao, Liu Dongsheng. Correlation between serum levels of HAMP, SPP1, RGS2 and clinical pathological characteristics of gastric cancer patients and their predictive value for postoperative recurrence or metastasis [J]. Journal of International Oncology, 2025, 52(8): 502-507. |
| [4] | Liu Shan, Pan Yue, Zhang Zhuo, Liu Chong, Li Xueman, Xiong Fei. Inhibition of the growth, migration, and angiogenesis of esophageal squamous cell carcinoma by metformin by regulating ALKBH3 expression [J]. Journal of International Oncology, 2025, 52(6): 343-352. |
| [5] | Liu Yiyong, Huo Fengzhi. Differential diagnosis model construction of invasive degree of lung adenocarcinoma manifesting as ground-glass nodules with no or little solid component based on energy spectrum CT features [J]. Journal of International Oncology, 2025, 52(4): 197-201. |
| [6] | Liu Qianyi, Dong Hongmin, Wang Wenling, Wang Gang, Chen Wanghua. Clinical efficacy and safety of radiotherapy combined with chemotherapy and immunotherapy for HER2-negative locally advanced or advanced gastric cancer [J]. Journal of International Oncology, 2025, 52(4): 209-216. |
| [7] | Ji Haitao, Wang Yanfeng, Liu Yongcheng, Hao Nan. Expression and clinical significance of DHCR7 in gastric cancer based on bioinformatics analysis [J]. Journal of International Oncology, 2025, 52(2): 94-100. |
| [8] | Ji Shengchao, Jin Xiaofeng, Ye Daixi, Lu Zehua, Xuan Lulu, Geng Chengjun. Diagnostic value of preoperative diffusion weighted imaging histogram parameters in the depth of invasion of early rectal cancer [J]. Journal of International Oncology, 2025, 52(10): 621-627. |
| [9] | Tan Rongjian, Ou Wenting, Zhai Jiawei, Quan Zhenhao, Sun Lijun, Zhou Caijin. Effects of RRM2 on malignant biological behavior and aerobic glycolysis of gastric cancer cells by regulating CDK1 [J]. Journal of International Oncology, 2025, 52(1): 23-30. |
| [10] | Wu Yang, Li Tian, Zhang Runbing, Shi Tingting, Gao Chun, Zheng Xiaofeng, Zhang Jiucong. Research progress in immunotherapy and targeted therapy for gastric cancer and esophagogastric junction cancer [J]. Journal of International Oncology, 2024, 51(9): 595-600. |
| [11] | Liu Wenhui, Yin Ping, Qi Jie. Diagnostic value of detection of serum G-17,sB7-H3,and DKK1 for early gastric cancer [J]. Journal of International Oncology, 2024, 51(8): 498-503. |
| [12] | Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343. |
| [13] | Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279. |
| [14] | Ren Lu, Xie Xiaoli, Zhang Kun, Wang Lijuan. Effects and mechanisms of dihydroartemisinin combined with carfilzomib on the activity, proliferation, and apoptosis of multiple myeloma cells [J]. Journal of International Oncology, 2024, 51(3): 129-136. |
| [15] | Xie Shuping, Sun Yahong, Wang Chao. Prediction of efficacy of early-stage tumor markers combined with NLR and PLR for immunotherapy in gastric cancer [J]. Journal of International Oncology, 2024, 51(3): 157-165. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||